H513 px330.sgActin.UTR.2 Citations (1)
Originally described in: CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling.Mou H, Ozata DM, Smith JL, Sheel A, Kwan SY, Hough S, Kucukural A, Kennedy Z, Cao Y, Xue W Genome Med. 2019 Apr 16;11(1):21. doi: 10.1186/s13073-019-0627-9. PubMed Journal
Articles Citing H513 px330.sgActin.UTR.2
| Articles |
|---|
| Generation of a spontaneous murine HPV + oral cancer model with site-specific oncogene insertion using CRISPR-SONIC. Tao J, Murray J, Tu HF, Fan D, Tsai YC, Hu MH, Wu AA, Xing D, Hung CF, Wu TC. Cell Biosci. 2025 Jun 18;15(1):84. doi: 10.1186/s13578-025-01427-5. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.